Nothing Special   »   [go: up one dir, main page]

Itoh et al., 1998 - Google Patents

Autoimmunity in chronic fatigue syndrome in children

Itoh et al., 1998

Document ID
13370141824184241073
Author
Itoh Y
Fukunaga Y
Igarashi T
Imai T
Yoshida J
Tsuchiya M
Fujino O
Murakami M
Yamamoto M
Publication year
Publication venue
Japanese journal of rheumatology

External Links

Snippet

We have reported that about half of children with chronic non-specific complaints were positive for antinuclear antibodies (ANA) and that the commonest complaint was fatigue in ANA-positive patients. Therefore, we have proposed a novel disease entity of autoimmune …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Woolf et al. Clinical manifestations of human parvovirus B19 in adults
Panayi et al. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.
Jacobs et al. A cytogenetic survey of an institution for the mentally retarded: I. Chromosome abnormalities
Garcia et al. Cysticercosis as a major cause of epilepsy in Peru
McLeod et al. Epidemiology of multiple sclerosis in Australia: with NSW and SA survey results
Kurtzke Epidemiologic evidence for multiple sclerosis as an infection
Kaiser Tick-borne encephalitis (TBE) in Germany and clinical course of the disease
Ludgate et al. Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.
Antoni et al. Psychological and neuroendocrine measures related to functional immune changes in anticipation of HIV-1 serostatus notification.
Rowe et al. Association of homozygous C4B deficiency with bacterial meningitis
US5538856A (en) Screening kit and method for diagnosing chronic immune dysfunction syndrome
Fukumori et al. A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan
Howell et al. IgG antiglobulin levels in patients with psoriatic arthropathy, ankylosing spondylitis, and gout.
Cervera et al. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
Karakayalı et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report
Mahroum et al. The mosaic of autoimmunity–Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens
Denburg et al. Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus
Monier et al. Clinical and laboratory features of canine lupus syndromes
Herrod et al. The in vitro response of human lymphocytes to Pneumocystis carinii antigen.
Fulford et al. Leucocyte migration and cell-mediated immunity in syphilis.
Itoh et al. Autoimmunity in chronic fatigue syndrome in children
Dosik et al. Adult T-cell leukemia/lymphoma in Brooklyn
Walker et al. Association of MHC antigens with susceptibility to and severity of rheumatoid arthritis in multicase families.
Behan et al. Family studies of congenital heart block associated with Ro antibody.
Horn et al. Mixed connective tissue disease in siblings